Hyeon D.Y.; Nam D.; Han Y.; Kim D.K.; Kim G.; Kim D.; Bae J.; Back S.; Mun D.-G.; Madar I.H.; Lee H.; Kim S.-J.; Kim H.; Hyun S.; Kim C.R.; Choi S.A.; Kim Y.R.; Jeong J.; Jeon S.; Choo Y.W.; Lee K.B.; Kwon W.; Choi S.; Goo T.; Park T.; Suh Y.-A.; Kim H.; Ku J.-L.; Kim M.-S.; Paek E.; Park D.; Jung K.; Baek S.H.; Jang J.-Y, Hwang D.; Lee S.-W.; Nature Cancer, 4, 290-307, 2023
We report a proteogenomic analysis of pancreatic ductal adenocarcinoma (PDAC). Mutation–phosphorylation correlations identified signaling pathways associated with somatic mutations in significantly mutated genes. Messenger RNA–protein abundance correlations revealed potential prognostic biomarkers correlated with patient survival. Integrated clustering of mRNA, protein and phosphorylation data identified six PDAC subtypes. Cellular pathways represented by mRNA and protein signatures, defining the subtypes and compositions of cell types in the subtypes, characterized them as classical p rogenitor (TS1), squamous (TS2–4), immunogenic progenitor (IS1) and exocrine-like (IS2) subtypes. Compared with the mRNA data, protein and phosphorylation data further classified the squamous subtypes into activated stroma-enriched (TS2), invasive (TS3) and invasive-proliferative (TS4) squamous subtypes. ...